Cargando…
Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic–androgenic steroids (AAS)
Use of testosterone replacement therapy (TRT) and anabolic–androgenic steroids (AAS) has increased over the last 20 years, coinciding with an increase in men presenting with infertility and hypogonadism. Both agents have a detrimental effect on spermatogenesis and pose a clinical challenge in the se...
Autores principales: | Desai, Ankit, Yassin, Musaab, Cayetano, Axel, Tharakan, Tharu, Jayasena, Channa N., Minhas, Suks |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243576/ https://www.ncbi.nlm.nih.gov/pubmed/35783920 http://dx.doi.org/10.1177/17562872221105017 |
Ejemplares similares
-
Survey of endocrinologists managing recovery from anabolic androgenic steroid induced hypogonadism
por: Grant, Bonnie, et al.
Publicado: (2023) -
Penile implant surgery-managing complications
por: Cayetano-Alcaraz, Axel Alberto, et al.
Publicado: (2021) -
Investigating the basis of sexual dysfunction during late-onset hypogonadism
por: Tharakan, Tharu, et al.
Publicado: (2019) -
Non-obstructive azoospermia: current and future perspectives
por: Tharakan, Tharu, et al.
Publicado: (2021) -
The effects of testosterone replacement therapy on the prostate: a clinical perspective
por: Miah, Saiful, et al.
Publicado: (2019)